Subfatin, asprosin, alamandine and maresin-1 in cerebral ischemia, intracranial and subarachnoid hemorrhages
| dc.contributor.author | Albayrak, S. | |
| dc.contributor.author | Aydin, M. A. | |
| dc.contributor.author | Ugur, K. | |
| dc.contributor.author | Hanbeyoglu, O. | |
| dc.contributor.author | Aydin, S. | |
| dc.contributor.author | Erol, E. | |
| dc.contributor.author | Aydin, S. | |
| dc.date.accessioned | 2026-08-12T16:58:00Z | |
| dc.date.issued | 2023 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | - OBJECTIVE: Cerebrovascular diseases (CVDs) remain an important public health issue due to the increasing number of deaths worldwide. Changes in the synthesis and release of peptides in CVDs may play an im-portant role in elucidating the physiopathology | |
| dc.identifier.endpage | 4480 | |
| dc.identifier.issn | 1128-3602 | |
| dc.identifier.issue | 10 | |
| dc.identifier.pmid | 37259728 | |
| dc.identifier.scopus | 2-s2.0-85160789219 | |
| dc.identifier.scopusquality | N/A | |
| dc.identifier.startpage | 4471 | |
| dc.identifier.uri | https://hdl.handle.net/11508/46666 | |
| dc.identifier.volume | 27 | |
| dc.identifier.wos | WOS:001021187100018 | |
| dc.identifier.wosquality | N/A | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Verduci Publisher | |
| dc.relation.ispartof | European Review for Medical and Pharmacological Sciences | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.subject | Maresin-1 | |
| dc.subject | Subfatin | |
| dc.subject | Asprosin | |
| dc.subject | Alamandine | |
| dc.subject | Cere-bral ischemia | |
| dc.subject | Hemorrhagy | |
| dc.title | Subfatin, asprosin, alamandine and maresin-1 in cerebral ischemia, intracranial and subarachnoid hemorrhages | |
| dc.type | Article |







